GEORGE RAAD: Open Payments
NPI 1679513998 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 58 payments from 21 companies in 2025. Trend: 2023 $2,540 · 2024 $2,162 · 2025 $1,112
Food & beverage: $1,112
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $225 |
| Lilly USA, LLC | 9 | $136 |
| Amgen Inc. | 4 | $79 |
| ABBVIE INC. | 3 | $63 |
| Novo Nordisk Inc | 3 | $58 |
| Astellas Pharma US Inc | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| SANOFI-AVENTIS U.S. LLC | 3 | $54 |
| Exact Sciences Corporation | 3 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $44 |
Products named: MOUNJARO, REXULTI, REPATHA, FARXIGA, BREZTRI, Veozah, TZIELD, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
